W. Buczko et al., MODULATION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 BIOSYNTHESIS IN-VITRO AND IN-VIVO WITH OLIGO(NUCLEOSIDE PHOSPHOROTHIOATE)S AND RELATEDCONSTRUCTS, Pharmacology & therapeutics, 76(1-3), 1997, pp. 161-175
Oligonucleotides with a nucleotide sequence complementary to various r
egions of human plasminogen activator inhibitor type-1 (PAI-1) mRNA ha
ve been studied as antisense inhibitors of expression of PAI-1 protein
in cultured cells [human umbilical vein endothelial cells (HUVEC), hu
man aortic smooth muscle cells, human hybrid endothelial cells]. Hexad
eca(deoxyribonucleoside phosphorothioate) 13 complementary to a fragme
nt of a signal peptide PAI-1 mRNA was found to be most active, giving
ca. 70% inhibition of PAI-1 release in a time-and dose-dependent way.
The stereo-regular All-S-p and All-R-p diastereomers of 13 were studie
d and found to inhibit PAI-1 synthesis in HUVEC in a stereo-dependent
manner, with the All-S-p diastereomer considerably more active than th
e stereo-random construct and All-R-p isomer. The observed stereo depe
ndent activity of oligonucleotide phosphorothioate constructs is presu
mably governed by their resistance to nucleases. The corresponding pho
sphodiester analogue of 13 was not active unless covalently bound at i
ts 5'-end to a lipophilic alcohol residue (menthol, heptadecanol). The
observed antisense activity of phosphodiester oligonucleotide bioconj
ugates in cultured human hybrid endothelial cells was paralleled by th
eir increased stability in human plasma with respect to unconjugated o
ligonucleotide. The oligo(deoxyribonucleoside phosphorothioate) comple
mentary to the same signal peptide region of rat PAI-1 mRNA was found
to reduce the PAI-1 level in blood plasma of rats after intravenous ad
ministration into the tail vein. The effect was both time-and dose dep
endent. The same oligonucleotide was found to protect against arterial
thrombus formation in the rat (lower incidence of venous thrombosis,
lower thrombus weight, and increased occlusion time in experimentally
induced thrombosis). An anti-PAI-l inhibitory activity has been indepe
ndently reported for a 20-mer oligo(2'-O-methyl-ribonucleoside phospho
rothioate) complementary to a 3'-untranslated region of human PAI-1 mR
NA in cultured HUVEC and human aortic smooth muscle cells. (C) 1997 El
sevier Science, Inc.